Skip to main content
TipRanks
Go Ultimate75% OFF

Cboe Global Markets (C67) AI Stock Analysis

1 Followers
DE:C67

Cboe Global Markets

(XETRA:C67)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue and margin expansionCboe is converting revenue growth into substantially stronger profitability, with both net and operating margins expanding. This indicates operating leverage and improved efficiency that can support reinvestment, strengthen resilience, and increase earnings capacity over the next several quarters.
Negative Factors
Volatile cash conversionThe sharp reduction in trailing cash generation relative to recent annual results makes earnings conversion less predictable. Persistent cash-flow volatility could constrain capital allocation flexibility and reduce the certainty with which Cboe can fund investment, debt repayment, or shareholder returns.

Cboe Global Markets (C67) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%50%60%DE:C67+55.86%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 39.17B
Dividend Yield
0.78%
Average Volume (3M)
33
Price to Earnings (P/E)
26.6
Beta (1Y)
0.10
Revenue Growth
8.56%
EPS Growth
43.93%
Country
Germany
Employees
1,661
Sector
Financial
Sector Strength
68
Industry
Financial - Data & Stock Exchanges

Cboe Global Markets Business Overview & Revenue Model

Company Description

Cboe Global Markets, Inc. functions as a global operator of various financial exchanges, primarily renowned for its options trading platforms, all managed through its numerous subsidiaries. The company organizes its expansive business activities into...

Cboe Global Markets Earnings Call Summary

Earnings Call Date:Oct 30, 2026(Q3-2026)|% Change Since:21.91%|Next Earnings Date:Jan 29, 2027
Earnings Call SentimentPositive

The call was strongly positive, with record earnings, broad-based revenue growth, robust options and retail activity, raised 2026 revenue guidance, strong balance-sheet flexibility, and progress on long-term initiatives such as the S&P agreement, KPI contracts, clearing, and extended trading hours. The main negatives were muted VIX and futures activity, a $14 million CAT LLC reserve, the loss of future Cboe Australia revenue, technology-cost inflation, and the early-stage nature and regulatory complexity of KPI contracts. Highlights significantly outweighed lowlights.

Positive Updates

Strong Third-Quarter Revenue and Earnings Growth
Net revenue increased 18% year-over-year to $712 million, while adjusted diluted EPS rose 36% to $3.63. GAAP diluted EPS reached a record $4.08, helped by a gain from the sale of Cboe Australia.

Negative Updates

Muted VIX Options Activity
VIX options average daily volume increased only 3% year-over-year because volatility remained stable, with the VIX in a tight 14-20 range and providing investors with fewer opportunities to monetize their views.

Company Guidance

For 2026, Cboe expects total organic net revenue growth to be in the high teens, with total net revenue growth to finish in the high teens range, including approximately $20 million from Cboe Australia through July 31st; DataVantage organic net revenue growth is expected in the mid-teens range and total DataVantage net revenue growth in the low to mid-teens, including approximately $17 million from Cboe Australia. Adjusted operating expenses are expected at $830 million-$845 million, including $20 million-$25 million of 2026 savings from the strategic realignment, with an annualized run rate of $40 million-$50 million; CapEx is expected at $98 million-$108 million, depreciation and amortization at $54 million-$58 million, and the full-year effective tax rate on adjusted earnings at 27.5%-29.5%. The S&P agreement extension will have no impact on 2026 net revenues, while the increase in 2027 royalty fee terms is expected to have a de minimis impact on 2027 net revenues; 2027 is the largest step-up, with it moderating a bit, starting in 2028. Net interest income net of expense is expected to contribute $12 million-$13 million positively in the fourth quarter, with a $2 million positive quarterly impact to non-operating income from the transition services agreement with TMX.

Cboe Global Markets Risk Analysis

Cboe Global Markets disclosed 36 risk factors in its most recent earnings report. Cboe Global Markets reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Cboe Global Markets Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

DE:C67 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
CMECME85Outperform$113.81B25.9316.24%3.55%8.99%18.85%
ICEICE83Outperform$99.76B24.2514.08%1.14%13.51%33.41%
NDAQNDAQ79Outperform$60.20B29.3217.29%1.07%11.94%30.40%
SPGISPGI79Outperform$137.29B28.1617.54%0.78%5.99%22.20%
MSCIMSCI74Outperform$47.06B35.01-49.71%1.25%12.33%19.69%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%

* Financial Sector Average

Performance Comparison

-20%0%20%40%DE:C67CMEICESPGIMSCINDAQDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:C67 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:C67Cboe Global Markets341.60120.7454.67%
CMECME Group Inc317.9749.2718.34%
ICEIntercontinental Exchange Inc.178.5130.1620.33%
SPGIS&P Global473.5915.193.31%
MSCIMSCI Inc658.17108.1419.66%
NDAQNasdaq OMX108.4723.8928.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.